Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The hidden danger of primary fluconazole prophylaxis for patients with AIDS.

Literature DB >> 9455533

The hidden danger of primary fluconazole prophylaxis for patients with AIDS.

J Berg¹, C J Clancy, M H Nguyen.

Abstract

Entities: Chemical Disease Species

Mesh：

Substances：

Year: 1998 PMID： 9455533 DOI： 10.1086/517056

Source DB: PubMed Journal: Clin Infect Dis ISSN： 1058-4838 Impact factor: 9.079

Keyword Cloud
Cited

× No keyword cloud information.

23 in total

1. Topoisomerase I is essential in Cryptococcus neoformans: role In pathobiology and as an antifungal target.

Authors: M Del Poeta; D L Toffaletti; T H Rude; C C Dykstra; J Heitman; J R Perfect
Journal: Genetics Date: 1999-05 Impact factor: 4.562

Review 2. Stress, drugs, and evolution: the role of cellular signaling in fungal drug resistance.

Authors: Leah E Cowen; William J Steinbach
Journal: Eukaryot Cell Date: 2008-03-28

3. In vitro activities of ravuconazole (BMS-207147) against 541 clinical isolates of Cryptococcus neoformans.

Authors: T Yamazumi; M A Pfaller; S A Messer; A Houston; R J Hollis; R N Jones
Journal: Antimicrob Agents Chemother Date: 2000-10 Impact factor: 5.191

4. In vitro activities of voriconazole, fluconazole, and itraconazole against 566 clinical isolates of Cryptococcus neoformans from the United States and Africa.

Authors: M A Pfaller; J Zhang; S A Messer; M E Brandt; R A Hajjeh; C J Jessup; M Tumberland; E K Mbidde; M A Ghannoum
Journal: Antimicrob Agents Chemother Date: 1999-01 Impact factor: 5.191

5. Trends in antifungal drug susceptibility of Cryptococcus neoformans isolates obtained through population-based surveillance in South Africa in 2002-2003 and 2007-2008.

Authors: Nelesh P Govender; Jaymati Patel; Marelize van Wyk; Tom M Chiller; Shawn R Lockhart
Journal: Antimicrob Agents Chemother Date: 2011-03-28 Impact factor: 5.191

The hidden danger of primary fluconazole prophylaxis for patients with AIDS.

1. Topoisomerase I is essential in Cryptococcus neoformans: role In pathobiology and as an antifungal target.

Review 2. Stress, drugs, and evolution: the role of cellular signaling in fungal drug resistance.

3. In vitro activities of ravuconazole (BMS-207147) against 541 clinical isolates of Cryptococcus neoformans.

4. In vitro activities of voriconazole, fluconazole, and itraconazole against 566 clinical isolates of Cryptococcus neoformans from the United States and Africa.

5. Trends in antifungal drug susceptibility of Cryptococcus neoformans isolates obtained through population-based surveillance in South Africa in 2002-2003 and 2007-2008.

6. Dynamic and heterogeneous mutations to fluconazole resistance in Cryptococcus neoformans.

7. Heteroresistance of Cryptococcus gattii to fluconazole.

8. Heteroresistance to fluconazole and voriconazole in Cryptococcus neoformans.

9. Cryptococcus neoformans overcomes stress of azole drugs by formation of disomy in specific multiple chromosomes.

10. A glucan synthase FKS1 homolog in cryptococcus neoformans is single copy and encodes an essential function.